Jaguar Animal Health (NASDAQ:JAGX) Share Price Passes Below 200-Day Moving Average – Here’s What Happened

Shares of Jaguar Animal Health, Inc. (NASDAQ:JAGX) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.05 and traded as low as $0.3911. Jaguar Animal Health shares last traded at $0.4065, with a volume of 626,578 shares trading hands.

Analysts Set New Price Targets

Several equities research analysts have issued reports on JAGX shares. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Jaguar Animal Health in a research note on Thursday, January 22nd. Wall Street Zen downgraded shares of Jaguar Animal Health to a “strong sell” rating in a research note on Friday, January 23rd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $60.00.

Jaguar Animal Health Stock Performance

The firm has a market cap of $5.29 million, a PE ratio of -0.01 and a beta of 0.27. The stock has a 50-day moving average price of $0.51 and a 200 day moving average price of $1.05. The company has a debt-to-equity ratio of 4.08, a current ratio of 0.50 and a quick ratio of 0.29.

About Jaguar Animal Health

Jaguar Animal Health, Inc is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the gastrointestinal health of food-producing animals, with an emphasis on swine and poultry. The company’s research and development efforts target common enteric disorders such as post-weaning diarrhea in pigs and clostridial overgrowth in broiler chickens, aiming to provide effective alternatives to traditional antibiotic treatments.

Jaguar Animal Health was formed in early 2019 through the acquisition of the animal health business of Aratana Therapeutics by Actinium Animal Health, followed by a corporate rebranding.